Yufei Jiang

Yufei Jiang

Auto-generated profile, based on publicly available information

Yufei Jiang

Centre for Health Economics at Warwick, Warwick Medical School, University of Warwick, Coventry, UK

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2025 in BMJ Open Gastroenterology
Verified
Journal Article
Open access
PDF file
MZMandana Zanganeh
Mandana Zanganeh
YJYufei Jiang
Yufei Jiang
ABAnna Brown
Anna Brown
YCYen-Fu Chen
Yen-Fu Chen
RARamesh Arasaradnam
Ramesh Arasaradnam
LALazaros Andronis
Lazaros Andronis
Objectives In many countries, single-use endoscopy accessories such as forceps have almost replaced their reusable counterparts. We reviewed the evidence on the broader economic cost and environmental impacts associated with single-use and multiple-use accessories for gastrointestinal (GI) endoscopes. Design Systematic review following the reporting guidelines of Preferred Reporting Items for Systematic Reviews and Meta-Analyses. Data sources MEDLINE, Embase, Web of Science and Cochrane Database of Systematic Reviews were searched from 1 January 2000 to 25 September 2024. Eligibility criteria We included published economic evaluations on single-use and reusable GI endoscope accessories which were written in English. Data extraction and synthesis Two independent reviewers extracted data and quality-assessed identified studies according to the Consensus on Health Economic Criteria checklist. Results Seven economic analyses were included: all were cost analyses. Three studies were from the USA, three from Europe and one from Korea. Patients in these studies underwent GI endoscopy (n=3), colonoscopy (n=2), gastroscopy (n=1) and endoscopic retrograde cholangiopancreatography (n=1). All studies compared single-use with reusable accessories, of which six were forceps. Reprocessing and purchase costs were included in all studies, repair costs were included in three studies, and environmental impact was only considered in one study. Most studies (n=5) reported a higher cost per procedure associated with single-use accessories. Conclusions Apart from two studies, all studies indicated that the cost per procedure was greater using single-use accessories/forceps. Future economic evaluations of single versus reusable accessories/forceps should include costs and also consequences of health and beyond, especially environmental impact.

18 April 2025 in Knee Surgery, Sports Traumatology, Arthroscopy
Verified
Journal Article
Open access
YJYufei Jiang
Yufei Jiang
SNSeyran Naghdi
Seyran Naghdi
NSNick Smith
Nick Smith
Toby SmithToby Smith
Toby Smith
AMAndrew Metcalfe
Andrew Metcalfe
HMHema Mistry
Hema Mistry
Purpose: Synthetic augmentation (SA) in anterior cruciate ligament reconstruction (ACLR) aims to enhance graft durability, but its benefits remain unclear. To evaluate whether SA in ACLR improves return‐to‐sport (RTS) rates, reduces graft failure, enhances patient‐reported outcomes (PROs) and varies in effectiveness across materials and techniques. Methods: A systematic search of five databases was conducted until February 2025. Comparative studies were pooled using Hedges' random‐effects meta‐analysis with subgroup analysis based on materials and publication year. Non‐comparative studies were analysed narratively. Risk of bias was assessed using the Risk of Bias in Non‐randomised Studies of Interventions and the Cochrane risk‐of‐bias tools for randomised studies. Grades of Recommendation, Assessment, Development and Evaluation (GRADE) approach was used to assess the certainty of evidence. Results: Forty‐seven studies were included ( n = 4289): 7 randomised and 40 non‐randomised studies (21 comparative; 19 non‐comparative). SA systems included InternalBrace (FiberTape, 16 studies), Ligament Augmentation and Reconstruction System (polyester, 5), Ligament Augmentation Device (polyethylene, 18) and other materials (8). GRADE assessment showed moderate‐certainty evidence for improved mid‐term RTS rate from eight studies (odds ratio [OR]: 1.58; 95% confidence interval (CI): 1.12–2.22; N = 716; I 2 = 0%; p = 0.01). Internal brace showed a reduction in re‐rupture rates in the long‐term (OR: 0.17, 95% CI: 0.04–0.64; N = 218; I 2 = 0%; p = 0.01); however, pooled analysis of all techniques showed no statistically significant difference. Contemporary studies showed a better return to sport rates with SA. PROs showed no clinically meaningful differences. Non‐comparative studies showed low graft failure rates (<8.7% for InternalBrace; 90% for InternalBrace; >56.7% for other SA) and satisfactory PROs. Conclusions: SA, particularly InternalBrace, may improve RTS rates and reduce re‐rupture risk, though PROs remain inconclusive. Findings are limited by a moderate‐to‐serious risk of bias, emphasising the need for high‐quality research. Level of Evidence: Level III.

22 October 2025 in BMJ Open Gastroenterology
Verified
Journal Article
Open access
PDF file
MZMandana Zanganeh
Mandana Zanganeh
YJYufei Jiang
Yufei Jiang
NWNorman Waugh
Norman Waugh
BHBu'Hussain Hayee
Bu'Hussain Hayee
SSShaji Sebastian
Shaji Sebastian
OGOn behalf of SUMU Endo project group
On behalf of SUMU Endo project group
Objective: We aimed to quantify the per-procedure costs of acquiring, maintaining/repairing and reprocessing reusable gastrointestinal endoscopes by observing practices in a large National Health Service (NHS) hospital. Methods: We conducted a bottom-up micro-costing analysis to capture the costs of reusable gastrointestinal endoscopes using a detailed resource-use data sheet and observations at the University Hospital Coventry and Warwickshire (UHCW). The data sheet drew on the published literature and NHS decontamination guidance. Cost categories included (1) measuring personnel time for reprocessing endoscopes, (2) reprocessing materials and (3) acquisition and maintenance/repair of endoscopy and reprocessing equipment. Data were obtained through observation and interviews with staff. Costs were calculated using the data collected at UHCW and cross-checked with data from two other NHS Trusts, manufacturers and the literature. Results: Staff time for reprocessing averaged 35 min per procedure (£23.57: 22% of the total cost). The reprocessing materials’ cost per procedure was £16.41 (15% of the total cost). Total capital acquisition cost per procedure was £46.9 (44% of the total cost), including endoscopy capital (£37.4) and reprocessing capital (£9.5). Total maintenance/repair cost per procedure was £20.46 (19% of the total cost). These led to a total cost of £107.34 per endoscopy procedure. Conclusions: Some observed values were slightly lower than but generally comparable to similar studies. We identified the key drivers of costs, led by capital costs. The results of our study could be used in economic evaluations involving reusable gastrointestinal endoscopes. The methodology can inform the cost evaluation of medical devices that require intensive reprocessing.